REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 10.7 billion by 2030 | 9.1 % | North America |
by Product | by Stage | by End-User |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Enteral Feeding Formulas Market Overview
The global enteral feeding formula market is expected to grow at 9.1 % CAGR from 2020 to 2030. It is expected to reach above USD 10.7 billion by 2030 from USD 5.8 billion in 2023
Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid or powdered nutritional products designed for individuals who are unable to consume adequate nutrition orally. These formulas are administered through a feeding tube directly into the gastrointestinal tract.
Enteral feeding formulas are specially formulated to provide a balanced combination of macronutrients (carbohydrates, proteins, and fats), vitamins, minerals, and other essential nutrients. They are designed to meet the specific nutritional requirements of individuals who cannot consume a regular diet due to medical conditions or swallowing difficulties. These formulas help ensure that patients receive the necessary nutrients to support their overall health and well-being. In situations where patients are recovering from surgery, illness, or injury, enteral feeding formulas can provide the necessary nutrients to support the healing process. They help promote tissue repair, maintain immune function, and prevent malnutrition, which is particularly important for patients with compromised health or weakened immune systems.
Enteral feeding formulas are crucial in preventing and treating malnutrition. Malnutrition can occur in individuals with conditions such as cancer, gastrointestinal disorders, neurological disorders, or prolonged illness. Enteral feeding formulas supply adequate nutrition to prevent weight loss, muscle wasting, nutrient deficiencies, and other complications associated with malnutrition. Enteral feeding formulas are administered directly into the gastrointestinal tract, which helps maintain the function of the digestive system. This stimulation can be beneficial for patients who have limited oral intake or impaired gastrointestinal function. It supports the absorption of nutrients, maintains gut integrity, and prevents gastrointestinal complications. For individuals who are unable to eat or have difficulty swallowing, enteral feeding formulas provide a means to receive adequate nutrition and hydration. This helps improve their overall quality of life by reducing discomfort, preventing hunger, and promoting energy levels. Enteral feeding formulas can be administered in various settings, including hospitals, long-term care facilities, and home-based care, allowing patients to receive nutrition support while maintaining their daily activities and routines. Enteral feeding formulas are available in a wide range of formulations, allowing healthcare professionals to select the most appropriate formula for each patient’s specific needs. Specialized formulas are available for individuals with specific medical conditions, such as diabetes, renal failure, or liver disease, ensuring that their nutritional requirements are met while considering their unique dietary restrictions and therapeutic needs. Overall, the increasing prevalence of chronic diseases, the aging population, advancements in medical technology, expanding home-based care, and rising awareness among healthcare professionals and patients are the key factors driving the growth of the enteral feeding formula market.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion) |
Segmentation | By Product, By Stage, By Disease, By End-User, By Application, By Region |
By Product
 |
|
By Stage
 |
|
By End-User |
|
By Application |
|
By Region
 |
|
Enteral Feeding Formulas Market Segment Analysis
The global enteral feeding formulas market is segmented based on product, stage, end user, application, and region. By product, the market is bifurcated into Standard Formula, Disease-specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Other Disease, Specific Formula, Peptide-based formula Other Formula. By stage, the market is bifurcated into adults and pediatrics. By end user the market is bifurcated into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, Home Care Agencies & Hospices. By application, the market is bifurcated into Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and other application.
Based on the product Standard Formula segment dominating in the Enteral Feeding Formulas Market. Standard formulas are designed to provide a balanced combination of macronutrients (carbohydrates, proteins, and fats), vitamins, and minerals, and they are suitable for individuals with normal digestion and absorption capabilities. Standard formulas are versatile and can be used for a variety of patient populations, including those without specific dietary restrictions or medical conditions that require specialized formulas. They are often the first choice for patients who require enteral nutrition support but do not have specific nutritional needs or restrictions. Standard formulas have been widely used for many years and have a long history of safe and effective use. Healthcare professionals are familiar with these formulas and often prescribe them as a starting point for enteral nutrition therapy.
Standard formulas are generally more cost-effective compared to specialized formulas. Since they have a broader target population, they are often produced in larger volumes, leading to economies of scale and lower manufacturing costs. Standard formulas are readily available from various manufacturers, making them easily accessible to healthcare providers and patients. This widespread availability contributes to their dominance in the market. Factors such as advancements in medical research, growing awareness of nutrition therapy, and the introduction of innovative formulas can influence the market dynamics and potentially shift the dominance from the standard formula segment to specialized segments in the future.
Based on the end-use industry hospital segment dominating in the Enteral Feeding Formulas Market. Hospitals typically have a high volume of patients who require enteral feeding due to various medical conditions or surgical procedures. The hospital setting encompasses a wide range of departments, including intensive care units, surgical units, and medical wards, where patients may need enteral nutrition support. This high patient volume contributes to the dominant position of hospitals in the market. Hospitals primarily cater to acute care needs, where patients require immediate medical attention and support. In acute care settings, enteral feeding is frequently employed as a part of the overall treatment plan to ensure patients receive adequate nutrition during their hospital stay. The need for enteral feeding formulas in these acute care settings further strengthens the dominance of hospitals in the market. Hospitals provide inpatient services, meaning patients stay within the hospital premises for an extended period. During this time, if patients are unable to consume a regular diet orally, enteral feeding formulas become an essential means of providing nutrition. Hospitals have the necessary infrastructure, medical professionals, and facilities to administer and monitor enteral nutrition, making them the preferred setting for enteral feeding. Hospitals offer specialized medical care for patients with complex medical conditions or those requiring specialized treatments. These patients often have specific nutritional requirements that may necessitate the use of specialized enteral feeding formulas. Hospitals have access to a wide range of enteral feeding formulas, including disease-specific formulas or formulas designed for specific patient populations, allowing them to cater to diverse patient needs. Hospitals have a multidisciplinary team of healthcare professionals, including dietitians, doctors, nurses, and pharmacists, who collaborate to determine the most appropriate enteral feeding formula for each patient. Their expertise in nutritional assessment, formulation selection, and monitoring contributes to the dominance of the hospital segment in the market.
Enteral Feeding Formulas Market Key Players
The Enteral Feeding Formulas Market Key Players Include Abbott, Nestlé, Danone S.A., Fresenius Kabi, B. Braun Melsungen Ag, Otsuka Holdings Co., Ltd., Nutritional Medicinals, Llc, Kate Farms, Medtrition Inc., Victus, Inc, Global Health Products Inc, Meiji Holdings, Reckitt Benckiser Group.
Orgain, a pioneer in plant-based nutrition, and Nestlé (Switzerland) have a deal in place for Nestlé to acquire the majority of Orgain’s stock in February 2023. This acquisition would improve the nutrition products that Nestlé Health Science already offers.
In September 2022, Abbott (US) launched enteral formulations for tube feeding that used organic dietary components and plant-based proteins.
Who Should Buy? Or Key stakeholders
- Enteral Feeding Formulas Supplier
- Pharmaceutical Industry
- Contract Research Organizations
- Investors
- Academic & Research Institutes
- Nursing Home Centers
- Hospitals and Diagnostics Centers
- Regulatory Authorities
- Home Care Agencies & Hospices
- Others
Enteral Feeding Formulas Market Regional Analysis
The Enteral Feeding Formulas market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
- Europe: includes the UK, Germany, France, Italy, Spain, Russia, the and Rest of Europe
- South America: includes Brazil, Argentina, and the Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA
In 2022, North America accounted for the largest market in the enteral feeding formulas market. North America is known for its advanced healthcare infrastructure, including well-established hospitals, clinics, and healthcare systems. This infrastructure facilitates the use of enteral feeding formulas in various healthcare settings, such as hospitals, long-term care facilities, and home-based care. The availability of healthcare facilities and resources contributes to the dominant position of North America in the market. North America has a relatively high prevalence of chronic diseases such as cancer, diabetes, gastrointestinal disorders, and neurological conditions. Many of these conditions require enteral nutrition support as a part of the overall treatment plan. The significant patient population with chronic diseases increases the demand for enteral feeding formulas in the region. North America has a significant aging population, with a large number of older adults who may require enteral feeding due to age-related conditions or illnesses. Aging is often associated with an increased risk of swallowing difficulties, malnutrition, and other health issues that necessitate enteral nutrition support. The aging population in North America contributes to the dominant position of the region in the market.
Key Market Segments: Enteral Feeding Formulas Market
Enteral Feeding Formulas Market by Product, 2020-2030, (USD Billion)
- Standard Formula
- Disease specific
- Diabetic Formula
- Renal Formula
- Hepatic Formula
- Pulmonary Formula
- Other Disease Specific Formula
- Peptide-based formula
- Other Formula
Enteral Feeding Formulas Market by Stage, 2020-2030, (USD Billion)
- Adults
- Pediatric
Enteral Feeding Formulas Market by End-User, 2020-2030, (USD Billion)
- Hospitals
- Long Term Care facilities
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies & Hospices
Enteral Feeding Formulas Market by Application, 2020-2030, (USD Billion)
- Oncology
- Gastrointestinal Diseases
- Neurological Disorders
- Diabetes
- Other Applications
Enteral Feeding Formulas Market by Region, 2020-2030, (USD Billion)
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the current size of the enteral feeding formulas market?
- What is the expected growth rate of the enteral feeding formulas market over the next 5 years?
- Who are the major players in the enteral feeding formulas market and what is their market share?
- What are the end-user industries driving demand for the market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, the middle east, and Africa?
- How is the economic environment affecting the enteral feeding formulas market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the enteral feeding formulas market?
- What is the current and forecasted size and growth rate of the global enteral feeding formulas market?
- What are the key drivers of growth in the enteral feeding formulas market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the enteral feeding formulas market?
- What are the technological advancements and innovations in the enteral feeding formulas market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the enteral feeding formulas market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the enteral feeding formulas market?
- What are the service offerings specifications of leading players in the market?
- What is the pricing trend of enteral feeding formulas in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL ENTERAL FEEDING FORMULAS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON THE ENTERAL FEEDING FORMULAS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL ENTERAL FEEDING FORMULAS MARKET OUTLOOK
- GLOBAL ENTERAL FEEDING FORMULAS MARKET BY PRODUCT, 2020-2030, (USD BILLION)
- STANDARD FORMULA
- DISEASE-SPECIFIC FORMULA
- DIABETIC FORMULA
- RENAL FORMULA
- HEPATIC FORMULA
- PULMONARY FORMULA
- OTHER DISEASE-SPECIFIC FORMULA
- PEPTIDE-BASED FORMULA
- OTHER FORMULA
- GLOBAL ENTERAL FEEDING FORMULAS MARKET BY STAGE, 2020-2030, (USD BILLION)
- ADULTS
- PEDIATRIC
- GLOBAL ENTERAL FEEDING FORMULAS MARKET BY APPLICATION, 2020-2030, (USD BILLION)
- ONCOLOGY
- GASTROINTESTINAL DISEASES
- NEUROLOGICAL DISORDERS
- DIABETES
- OTHER APPLICATIONS
- GLOBAL ENTERAL FEEDING FORMULAS MARKET BY END-USER, 2020-2030, (USD BILLION)
- HOSPITALS
- LONG-TERM CARE FACILITIES
- NURSING HOMES
- ASSISTED LIVING FACILITIES
- HOME CARE AGENCIES & HOSPICES
- GLOBAL ENTERAL FEEDING FORMULAS MARKET BY REGION, 2020-2030, (USD BILLION)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
8.1. ABBOTT
8.2. NESTLÉ
8.3. DANONE S.A.
8.4. FRESENIUS KABI
8.5. B. BRAUN MELSUNGEN AG
8.6. OTSUKA HOLDINGS CO., LTD.
8.7. NUTRITIONAL MEDICINALS, LLC
8.8. KATE FARMS
8.9. MEDITATION INC.
8.10. VICTUS, INC.
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 2Â Â Â Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 3Â Â Â Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 4Â Â Â Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 5Â Â Â Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY REGION (USD BILLION) 2020-2030
TABLE 6Â Â Â Â Â Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 7Â Â Â Â Â Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 8Â Â Â Â Â Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 9Â Â Â Â Â Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 10Â Â Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 11Â Â Â Â Â Â US ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 12Â Â Â Â Â Â US ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 13Â Â Â Â Â Â US ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 14Â Â Â Â Â Â US ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 15Â Â Â Â Â Â CANADA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 16Â Â Â Â Â Â CANADA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 17Â Â Â Â Â Â CANADA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 18Â Â Â Â Â Â CANADA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 19Â Â Â Â Â Â MEXICO ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 20Â Â Â Â Â Â MEXICO ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 21Â Â Â Â Â Â MEXICO ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 22Â Â Â Â Â Â MEXICO ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 23Â Â Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 24Â Â Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 25Â Â Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 26Â Â Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 27Â Â Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 28Â Â Â Â Â Â BRAZIL ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 29Â Â Â Â Â Â BRAZIL ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 30Â Â Â Â Â Â BRAZIL ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 31Â Â Â Â Â Â BRAZIL ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 32Â Â Â Â Â Â ARGENTINA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 33Â Â Â Â Â Â ARGENTINA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 34Â Â Â Â Â Â ARGENTINA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 35Â Â Â Â Â Â ARGENTINA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 36Â Â Â Â Â Â COLOMBIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 37Â Â Â Â Â Â COLOMBIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 38Â Â Â Â Â Â COLOMBIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 39Â Â Â Â Â Â COLOMBIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 40Â Â Â Â Â Â REST OF SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 41Â Â Â Â Â Â REST OF SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 42Â Â Â Â Â Â REST OF THE SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 43Â Â Â Â Â Â REST OF SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 44Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 45Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 46Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 47Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 48Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 49Â Â Â Â Â Â INDIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 50Â Â Â Â Â Â INDIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 51Â Â Â Â Â Â INDIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 52Â Â Â Â Â Â INDIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 53Â Â Â Â Â Â CHINA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 54Â Â Â Â Â Â CHINA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 55Â Â Â Â Â Â CHINA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 56Â Â Â Â Â Â CHINA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 57Â Â Â Â Â Â JAPAN ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 58Â Â Â Â Â Â JAPAN ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 59Â Â Â Â Â Â JAPAN ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 60Â Â Â Â Â Â JAPAN ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 61Â Â Â Â Â Â SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 62Â Â Â Â Â Â SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 63Â Â Â Â Â Â SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 64Â Â Â Â Â Â SOUTH KOREA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 65Â Â Â Â Â Â AUSTRALIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 66Â Â Â Â Â Â AUSTRALIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 67Â Â Â Â Â Â AUSTRALIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 68Â Â Â Â Â Â AUSTRALIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 69Â Â Â Â Â Â SOUTH-EAST ASIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 70Â Â Â Â Â Â SOUTH-EAST ASIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 71Â Â Â Â Â Â SOUTH-EAST ASIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 72Â Â Â Â Â Â SOUTH-EAST ASIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 73Â Â Â Â Â Â REST OF ASIA PACIFIC ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 74Â Â Â Â Â Â REST OF ASIA PACIFIC ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 75Â Â Â Â Â Â REST OF ASIA PACIFIC ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 76Â Â Â Â Â Â REST OF ASIA PACIFIC ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 77Â Â Â Â Â Â EUROPE ENTERAL FEEDING FORMULAS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 78Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 79Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 80Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 81Â Â Â Â Â Â ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 82Â Â Â Â Â Â GERMANY ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 83Â Â Â Â Â Â GERMANY ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 84Â Â Â Â Â Â GERMANY ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 85Â Â Â Â Â Â GERMANY ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 86Â Â Â Â Â Â UK ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 87Â Â Â Â Â Â UK ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 88Â Â Â Â Â Â UK ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 89Â Â Â Â Â Â UK ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 90Â Â Â Â Â Â FRANCE ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 91Â Â Â Â Â Â FRANCE ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 92Â Â Â Â Â Â FRANCE ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 93Â Â Â Â Â Â FRANCE ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 94Â Â Â Â Â Â ITALY ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 95Â Â Â Â Â Â ITALY ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 96Â Â Â Â Â Â ITALY ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 97Â Â Â Â Â Â ITALY ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 98Â Â Â Â Â Â SPAIN ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 99Â Â Â Â Â Â SPAIN ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 100Â Â Â Â SPAIN ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 101Â Â Â Â SPAIN ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 102Â Â Â Â RUSSIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 103Â Â Â Â RUSSIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 104Â Â Â Â RUSSIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 105Â Â Â Â RUSSIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 106Â Â Â Â REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 107Â Â Â Â REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 108Â Â Â Â REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 109Â Â Â Â REST OF EUROPE ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 110Â Â Â Â MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 111Â Â Â Â MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 112Â Â Â Â MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 113Â Â Â Â MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 114Â Â Â Â MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 115Â Â Â Â UAE ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 116Â Â Â Â UAE ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 117Â Â Â Â UAE ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 118Â Â Â Â UAE ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 119Â Â Â Â SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 120Â Â Â Â SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 121Â Â Â Â SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 122Â Â Â Â SAUDI ARABIA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 123Â Â Â Â SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 124Â Â Â Â SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 125Â Â Â Â SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 126Â Â Â Â SOUTH AFRICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
TABLE 127Â Â Â Â REST OF THE MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 128Â Â Â Â REST OF MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY PRODUCT (USD BILLION) 2020-2030
TABLE 129Â Â Â Â REST OF THE MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY END-USER (USD BILLION) 2020-2030
TABLE 130Â Â Â Â REST OF THE MIDDLE EAST AND AFRICA ENTERAL FEEDING FORMULAS MARKET BY STAGE (USD BILLION) 2020-2030
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY PRODUCT, USD BILLION, 2020-2030
FIGURE 9Â Â Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY STAGE, USD BILLION, 2020-2030
FIGURE 10Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY APPLICATION, USD BILLION, 2020-2030
FIGURE 12Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY END-USER, USD BILLION, 2020-2030
FIGURE 11Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 12    PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY PRODUCT, USD BILLION, 2022
FIGURE 14Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY STAGE, USD BILLION, 2022
FIGURE 15Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY APPLICATION, USD BILLION, 2022
FIGURE 12Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY END-USER, USD BILLION, 2022
FIGURE 16Â Â Â Â GLOBAL ENTERAL FEEDING FORMULAS MARKET BY REGION, USD BILLION, 2022
FIGURE 17Â Â Â Â NORTH AMERICA ENTERAL FEEDING FORMULAS MARKET SNAPSHOT
FIGURE 18Â Â Â Â EUROPE ENTERAL FEEDING FORMULAS MARKET SNAPSHOT
FIGURE 19Â Â Â Â SOUTH AMERICA ENTERAL FEEDING FORMULAS MARKET SNAPSHOT
FIGURE 20Â Â Â Â ASIA PACIFIC ENTERAL FEEDING FORMULAS MARKET SNAPSHOT
FIGURE 21Â Â Â Â MIDDLE EAST ASIA AND AFRICA ENTERAL FEEDING FORMULAS MARKET SNAPSHOT
FIGURE 22Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 23Â Â Â Â ABBOTT: COMPANY SNAPSHOT
FIGURE 24    NESTLÉ: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â DANONE S.A.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â FRESENIUS KABI: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â OTSUKA HOLDINGS CO. LTD.: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â NUTRITIONAL MEDICINALS LLC: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â KATE FARMS: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â MEDTRITION INC: COMPANY SNAPSHOT
FIGURE 32Â Â Â Â VICTUS, INC: COMPANY SNAPSHOT
FAQ
The global enteral feeding formula market is expected to grow at 9.1 % CAGR from 2020 to 2030. It is expected to reach above USD 10.7 billion by 2030 from USD 5.8 billion in 2023
North America accounted for the largest market in the Enteral Feeding Formulas market. North America held more than 38% of the enteral feeding formulas market revenue share in 2020.
The prime factor driving the enteral feeding formulas market ahead is the Increasing demand for enteral feeding in-home care.
Development of new products and innovation this factor will create more opportunities in the enteral feeding formulas market.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.